Lam Research Corporation
NASDAQ:LRCXSemiconductors
+$19.70 today
- Market cap
- $264.41B
- Beta
- 1.87
- P/E (TTM)
- 73.4
- EPS (TTM)
- $5.37
- Dividend yield
- 0.26%
Volume 7.61M
Average 11.84M
LRCX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Lam Research CorporationNASDAQ: LRCX
EBITDA · Q1 FY2027 · quarter ended Sep 2026
EBITDA growth accelerates
Q1 FY2027 EBITDA of $3.43B rose 75.1% year over year, ahead of the +45.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 32.5% from the prior quarter. Over 3 fiscal years it compounded at +15.6% a year.
Context
- EBITDA amounted to 37.5% of revenue in FY2026, up 3.1 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 24 analysts of $14.34B (+64.8%) for the fiscal year ending Jun 2027, a step up from the +37.2% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $3.43B+32.5% QoQ
- Last fiscal yearJun 2026
- $8.7B+37.2% YoY
- LTMSep 2026
- $10.18B+45.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +75.1% | +74.7% | -0.4 pp |
| 1 year | +37.2% | +64.8% | +27.6 pp |
| 3-year CAGR | +15.6% | +34.3% | +18.7 pp |
| 5-year CAGR | +26.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- 8.7B USD
- Year-over-year change
- +37.2%
- 4-year CAGR
- +11.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-28 | 8.7B | +37.2% |
| FY2025 | 2025-06-29 | 6.34B | +29.3% |
| FY2024 | 2024-06-30 | 4.91B | -13.0% |
| FY2023 | 2023-06-25 | 5.64B | -1.3% |
| FY2022 | 2022-06-26 | 5.71B | — |
EBITDA vs competitors
How LRCX compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +45.2% is the highest of 6, against a peer median of +15.3%.
- EBITDA amounts to 38.9% of revenue for LRCX, versus a peer median of 35.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | €16.4B EUR | +32.1% | +20.5% | 41.5% | |
| LTM Oct 2026 | $12.38B USD | +24.2% | +13.6% | 35.9% | |
| LTM Sep 2026 | $10.18B USD | +45.2% | +15.6% | 38.9% | |
| LTM Jun 2026 | $6.05B USD | +13.4% | +10.4% | 44.6% | |
| LTM Sep 2026 | $219.7M USD | +15.3% | +28.7% | 19.3% | |
| LTM Sep 2026 | $43.58M USD | -41.6% | -8.0% | 6.0% | |
| Peer median (excluding LRCX) | — | +15.3% | +13.6% | 35.9% | |
Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 17.23B | 17.43B | 14.91B | 18.44B | 23.23B |
| Cost of Revenue | 9.36B | 9.65B | 7.85B | 9.46B | 11.51B |
| Gross Profit | 7.87B | 7.78B | 7.05B | 8.98B | 11.73B |
| Gross Margin | 45.7% | 44.6% | 47.3% | 48.7% | 50.5% |
| Research & Development | 1.6B | 1.73B | 1.9B | 2.1B | 2.38B |
| Selling, General & Admin | 885.74M | 832.75M | 868.25M | 981.7M | 1.15B |
| Operating Expenses | 2.49B | 2.6B | 2.79B | 3.08B | 3.53B |
| Depreciation & Amortization | 333.74M | 342.43M | 359.7M | 386.28M | 441.53M |
| EBITDA | 5.71B | 5.64B | 4.91B | 6.34B | 8.7B |
| EBITDA Margin | 33.2% | 32.4% | 32.9% | 34.4% | 37.5% |
| Operating Income | 5.38B | 5.17B | 4.26B | 5.9B | 8.2B |
| Operating Margin | 31.2% | 29.7% | 28.6% | 32.0% | 35.3% |
| Interest Income | 15.21M | 138.98M | 251.94M | 231.33M | 0 |
| Interest Expense | 184.76M | 186.46M | 185.24M | 178.2M | 0 |
| Other Income / Expenses | (188.71M) | (65.65M) | 96.31M | 57.16M | 62.68M |
| Income Before Tax | 5.19B | 5.11B | 4.36B | 5.96B | 8.26B |
| Pre-Tax Margin | 30.1% | 29.3% | 29.3% | 32.3% | 35.6% |
| Income Tax Expense | 587.83M | 598.28M | 532.45M | 599.91M | 997.08M |
| Net Income | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Net Margin | 26.7% | 25.9% | 25.7% | 29.1% | 31.3% |
| EPS (Basic) | 3.29 | 3.33 | 2.91 | 4.17 | 5.79 |
| EPS (Diluted) | 3.27 | 3.32 | 2.90 | 4.15 | 5.76 |
| Weighted Avg Shares | 1.4B | 1.35B | 1.31B | 1.29B | 1.26B |
| Weighted Avg Shares (Diluted) | 1.41B | 1.36B | 1.32B | 1.29B | 1.26B |
Lam Research Corporation
NASDAQ:LRCX
Intrinsic Alpha fair value
Locked
Current Price
$211.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.